PrecisionIR’s Informed Investors™ Biotechnology Forum Fosters Interaction Between High-Net-Worth Retail Investors and Company Executives
Over 745 investors hear directly from 12 Companies Including Acambis, AVANT Immunotherapeutics and Viragen, Inc.
Richmond, VA – July 30, 2004 – WILink, a global leader in providing investor relations and investment information services, today announced results of their Informed Investors™ Biotechnology Forum held in June in New York City. On June 23, over 95 investors attended the live forum held at The Princeton Club. In the week following the event, over 640 investors listened to the archived company presentations. Of the attendees, 91 were institutional investors, with 41 covering the biotechnology and pharmaceutical industries. Informed Investors™ Forums is part of the PrecisionIR™ suite of investor relations services that help companies communicate with the investor community.
Of the investors surveyed, 90% advised the forum had a positive effect on their investment decision about the presenting companies. Results from the forum attendee survey showed those who attended were experienced, wealthy investors. On average, they reported:
- Net worth of $1,018,000 USD
- Portfolio holdings of $556,000 USD
- Household income of $117,000
- Over 12 years of investment experience
Informed Investors™ Forums provides investors the opportunity to gain insight on specific industry stocks while hearing directly from company executives who present their corporate story to interested institutional and high net-worth investors. The direct question and answer sessions allow investors to review important details about the companies’ performance and strategy.
Speakers at the recent Biotechnology Forum included: Gordon Cameron, CEO, Acambis; Dr. Una Ryan, President and CEO, AVANT Immunotherapeutics; Stephen Simes, President and CEO, BioSante Pharmaceuticals; Leonard Kruimer, CFO, Crucell N.V.; David Green, President, Harvard Bioscience, Inc.; Robert Lollini, CEO, IOMED, Inc.; Jay M. Green, Executive Vice President, Inyx, Inc.; Paul Kelly M.D., CEO. Orchid BioSciences, Inc.; Peter McBride, Vice President- Investor Relations, Theratechnologies, Inc.; Charles Rice, President and CEO, Viragen, Inc.; Sean Thompson, Head of Business Development, YM BioSciences; and Dr. Chris Wood, Chairman and CEO, Bioenvision, Inc. Lynn Sutherland, President, Sutherland Consulting and Bill Alpert, Senior Editor and Biotechnology Writer for Barron’s delivered the forum keynote addresses. The Wall Street Journal and Barron’s sponsored this forum.
The forum presentations are archived at: http://www.informedinvestors.com/CustomEvent/85117/index.asp?ForumID=85117 and available for investors to access at their convenience.
Informed Investors Forums will host a live Biotechnology and Healthcare forum on September 29th, 2004 in San Francisco. For more information on this forum, please contact Cary Loeser at cloeser@wilink.com or 804 327 3407.
| Back to News | Back to Top |